The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Andreeva I.V.

Associate Professor, MD, PhD, Clinical Pharmacologist, Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk

Stetsyuk O.U.

MD, PhD, Clinical Pharmacologist, Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk

Andreev V.A.

6th year medical student, Smolensk State Medical University, Smolensk

Probiotics: 5 questions from the practitioner

Authors:

Andreeva I.V., Stetsyuk O.U., Andreev V.A.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2023;(1‑2): 68‑75

Read: 39010 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Andreeva IV, Stetsyuk OU, Andreev VA. Probiotics: 5 questions from the practitioner. Non Nocere. New Therapeutic Journal. 2023;(1‑2):68‑75. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Authors:

Andreeva I.V.

Associate Professor, MD, PhD, Clinical Pharmacologist, Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk

Stetsyuk O.U.

MD, PhD, Clinical Pharmacologist, Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk

Andreev V.A.

6th year medical student, Smolensk State Medical University, Smolensk

Close metadata

References:

  1. McFarland LV. From yaks to yogurt: the history, development, and current use of probiotics. Clin Infect Dis. 2015;60 Suppl 2: S85–90. doi: 10.1093/cid/civ054.
  2. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi: 10.1038/nrgastro.2014.66.
  3. Neut C, Mahieux S, Dubreuil LJ. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics? Med Mal Infect. 2017;47(7):477–483. doi: 10.1016/j.medmal.2017.07.001.
  4. Adams CA. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev. 2010;23(1):37–46. doi: 10.1017/S0954422410000090.
  5. D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ. 2002;324(7350):1361. doi: 10.1136/bmj.324.7350.1361.
  6. Cremonini F, Di Caro S, Nista EC, Bartolozzi F, Capelli G, Gasbarrini G, et al. Meta-analysis: the effect of probiotic administration on antibiotic-­associated diarrhoea. Aliment Pharmacol Ther. 2002;16(8):1461–7. doi: 10.1046/j.1365–2036.2002.01318.x.
  7. Szajewska H, Ruszczyński M, Radzikowski A. Probiotics in the prevention of antibiotic-­associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 2006;149(3):367–372. doi: 10.1016/j.jpeds.2006.04.053.
  8. Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-­associated diarrhea. Cochrane Database Syst Rev. 2011;11: CD004827. doi: 10.1002/14651858.CD004827.pub3.
  9. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-­associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959–1969. doi: 10.1001/jama.2012.3507.
  10. Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-­associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5: CD006095. doi: 10.1002/14651858.CD006095.pub3.
  11. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics for the prevention of pediatric antibiotic-­associated diarrhea. Cochrane Database Syst Rev. 2015;12: CD004827. doi: 10.1002/14651858.CD004827.pub4.
  12. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-­associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149–1157. doi: 10.1111/apt.13404.
  13. Jafarnejad S, Shab-­Bidar S, Speakman JR, Parastui K, Daneshi-­Maskooni M, Djafarian K. Probiotics Reduce the Risk of Antibiotic-­Associated Diarrhea in Adults (18–64 Years) but Not the Elderly (>65 Years): A Meta-­Analysis. Nutr Clin Pract. 2016;31(4):502–513. doi: 10.1177/0884533616639399.
  14. Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficile-­associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12: CD006095. doi: 10.1002/14651858.CD006095.pub4.
  15. Shen NT, Maw A, Tmanova LL, Pino A, Ancy K, Crawford CV, et al. Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-­Regression Analysis. Gastroenterology. 2017;152(8):1889–1900. doi: 10.1053/j.gastro.2017.02.003.
  16. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the Prevention of Antibiotic-­Associated Diarrhea in Outpatients – A Systematic Review and Meta-­Analysis. Antibiotics (Basel). 2017;6(4). pii: E21. doi: 10.3390/antibiotics6040021.
  17. Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-­associated diarrhea. Cochrane Database Syst Rev. 2019;4: CD004827. doi: 10.1002/14651858.CD004827.pub5.
  18. Ma Y, Yang JY, Peng X, Xiao KY, Xu Q, Wang C. Which probiotic has the best effect on preventing Clostridium difficile-­associated diarrhea? A systematic review and network meta-analysis. J Dig Dis. 2020;21(2):69–80. doi: 10.1111/1751–2980.12839.
  19. Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-­associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021;11(8): e043054. doi: 10.1136/bmjopen‑2020–043054.
  20. Liao W, Chen C, Wen T, Zhao Q. Probiotics for the Prevention of Antibiotic-­associated Diarrhea in Adults: A Meta-­Analysis of Randomized Placebo-­Controlled Trials. J Clin Gastroenterol. 2021;55(6):469–480. doi: 10.1097/MCG.0000000000001464.
  21. Williams Zhang L, Zeng X. Guo D, Zou Y, Gan H, Huang X. Early use of probiotics might prevent antibiotic-­associated diarrhea in elderly (>65 years): a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):562. doi: 10.1186/s12877–022–03257–3.
  22. WGO Practice Guideline. Probiotics and Prebiotics. World Gastroenterology Organization. 2012. Available at: http://www.worldgastroenterology.org/guidelines/global-­guidelines/probiotics-and-prebiotics. Accessed 15-JAN‑2023.
  23. Szajewska H, Canani RB, Guarino A, Hojsak I, Indrio F, Kolacek S, et al. ESPGHAN Working Group for Probiotics and Prebiotics. Probiotics for the Prevention of Antibiotic-­Associated Diarrhea in Children. J Pediatr Gastroenterol Nutr. 2016;62(3):495–506. doi: 10.1097/MPG.0000000000001081.
  24. Guarner F, Sanders ME, Eliakim R, Fedorak R, Gangl A, Garisch J, et al. World Gastroenterology Organization Global Guidelines. Probiotics and prebiotics. February 2017. Available at: https://www.worldgastroenterology.org/UserFiles/file/guidelines/probiotics-and-prebiotics-­english‑2.... Accessed 15-JAN‑2023.
  25. Williams NT. Probiotics. Am J Health Syst Pharm. 2010;67(6):449–458. doi: 10.2146/ajhp090168.
  26. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30. doi: 10.1136/gutjnl‑2016–312288.
  27. Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G, et al. Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol Clin Biol. 2002;26(3):216–219.
  28. Sanches B, Coelho L, Moretzsohn L, Vieira G Jr. Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. Helicobacter. 2008;13(6):572–576. doi: 10.1111/j.1523–5378.2008.00649.x.
  29. Gong Y, Li Y, Sun Q. Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials. Int J Clin Exp Med. 2015;8(4):6530–6543.
  30. Булгаков С. А. Побочные эффекты при антихеликобактерной терапии. Альманах клинической медицины. 2006;14:20–23.
  31. Marteau P, Rambaud JC. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev. 1993;12:207–220. doi: 10.1111/j.1574–6976.1993.tb00019.x.
  32. Захаренко С. М., Андреева И. В., Стецюк О. У. Нежелательные лекарственные реакции со стороны ЖКТ и антибиотикоассоциированная диарея при применении антибиотиков в амбулаторной практике: профилактика и лечение. Клиническая микробиология и антимикробная химиотерапия. 2019;21(3):196–206. doi: 10.36488/cmac.2019.3.196–206.
  33. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2007;25(2):155–68. doi: 10.1111/j.1365–2036.2006.03179.x.
  34. Zou J, Dong J, Yu X. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter. 2009;14(5):97–107. doi: 10.1111/j.1523–5378.2009.00716.x.
  35. Wang ZH, Gao QY, Fang JY. Meta-analysis of the efficacy and safety of Lactobacillus-­containing and Bifidobacterium-­containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol. 2013;47(1):25–32. doi: 10.1097/MCG.0b013e318266f6cf.
  36. Zheng X, Lyu L, Mei Z. Lactobacillus-­containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis. Rev Esp Enferm Dig. 2013;105(8):445–453. doi: 10.4321/s1130–01082013000800002.
  37. Li S, Huang XL, Sui JZ, Chen SY, Xie YT, Deng Y, et al. Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children. Eur J Pediatr. 2014;173(2):153–61. doi: 10.1007/s00431–013–2220–3.
  38. Lv Z, Wang B, Zhou X, Wang F, Xie Y, Zheng H, et al. Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis. Exp Ther Med. 2015;9(3):707–716. doi: 10.3892/etm.2015.2174.
  39. Zhang MM, Qian W, Qin YY, He J, Zhou YH. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis. World J Gastroenterol. 2015;21(14):4345–4357. doi: 10.3748/wjg.v21.i14.4345.
  40. Lü M, Yu S, Deng J. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-­Analysis of Randomized Controlled Trials. PLoS One. 2016;11(10): e0163743. doi: 10.1371/journal.pone.0163743.
  41. Si XB, Lan Y, Qiao L. A meta-analysis of randomized controlled trials of bismuth-­containing quadruple therapy combined with probiotic supplement for eradication of Helicobacter pylori. Zhonghua Nei Ke Za Zhi. 2017;56(10):752–759. doi: 10.3760/cma.j. issn.0578–1426.2017.10.009.
  42. Fang HR, Zhang GQ, Cheng JY, Li ZY. Efficacy of Lactobacillus-­supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials. Eur J Pediatr. 2019;178(1):7–16. doi: 10.1007/s00431–018–3282-z.
  43. Shi X, Zhang J, Mo L, Shi J, Qin M, Huang X. Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis. Medicine (Baltimore). 2019;98(15): e15180. doi: 10.1097/MD.0000000000015180.
  44. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. European Helicobacter Study Group Management of Helicobacter pylori infection – the Maastricht IV. Florence Consensus Report. Gut. 2012;61(5):646–664. doi: 10.1136/gutjnl‑2012–302084.
  45. Farnworth ER. The evidence to support health claims for probiotics. J Nutr. 2008;138(6):1250S‑1254S. doi: 10.1093/jn/138.6.1250S.
  46. Sniffen JC, McFarland LV, Evans CT, Goldstein EJC. Choosing an appropriate probiotic product for your patient: An evidence-­based practical guide. PLoS ONE. 2018;13(12): e0209205. doi: 10.1371/journal.pone.0209205.
  47. Ouwehand AC. A review of dose-responses of probiotics in human studies. Beneficial Microbes. 2017;8(2):143–151. doi: 10.3920/BM2016.0140.
  48. Hamilton-­Miller JMT. Probiotics – panacea or nostrum? British Nutrition Foundation Bulletin. 1996;21:199–208. doi: 10.1111/j.1467–3010.1996.tb00853.x
  49. Lee YK, Salminen S. The Coming of Age of Probiotics. Trends Food Sci Technol. 1995;6:241–245. doi: 10.1016/S0924–2244(00)89085–8.
  50. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001;322(7298):1327. doi: 10.1136/bmj.322.7298.1327.
  51. Näse L, Hatakka K, Savilahti E, Saxelin M, Pönkä A, Poussa T, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001;35(6):412–420. doi: 10.1159/000047484.
  52. Basu S, Chatterjee M, Ganguly S, Chandra PK. Effect of Lactobacillus rhamnosus GG in persistent diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol. 2007;41(8):756–760. doi: 10.1097/01.mcg.0000248009.47526.ea.
  53. Basu S, Paul DK, Ganguly S, Chatterjee M, Chandra PK. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol. 2009;43(3):208–213. doi: 10.1097/MCG.0b013e31815a5780.
  54. Kligler B, Cohrssen A. Probiotics. Am Fam Physician. 2008;78(9):1073–1078.
  55. Stavropoulou E, Bezirtzoglou E. Probiotics in Medicine: A Long Debate. Front Immunol. 2020;11:2192. doi: 10.3389/fimmu.2020.02192.
  56. Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr. 2014;58(4):531–539. doi: 10.1097/MPG.0000000000000320.
  57. Li BZ, Threapleton DE, Wang JY, Xu JM, Yuan JQ, Zhang C, et al. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ. 2015;351: h4052. doi: 10.1136/bmj.h4052.
  58. Zhang Y, Li L, Guo C, Mu D, Feng B, Zuo X, et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016;16(1):62. doi: 10.1186/s12876–016–0470-z.
  59. Zhao Y, Dong BR, Hao Q. Probiotics for preventing acute upper respiratory tract infections. cochrane database syst rev. 2022;8(8): CD006895. doi: 10.1002/14651858.CD006895.pub4.
  60. Jiang W, Ni B, Liu Z, Liu X, Xie W, Wu IXY, et al. The Role of Probiotics in the Prevention and Treatment of Atopic Dermatitis in Children: An Updated Systematic Review and Meta-­Analysis of Randomized Controlled Trials. Paediatr Drugs. 2020;22(5):535–549. doi: 10.1007/s40272–020–00410–6.
  61. Dalal R, McGee RG, Riordan SM, Webster AC. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;2(2): CD008716. doi: 10.1002/14651858.CD008716.pub3.
  62. Liu RT, Walsh RFL, Sheehan AE. Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev. 2019;102:13–23. doi: 10.1016/j.neubiorev.2019.03.023.
  63. Sanchez P, Letarouilly JG, Nguyen Y, Sigaux J, Barnetche T, Czernichow S, et al. Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-­Analysis of Randomized Controlled Trials. Nutrients. 2022;14(2):354. doi: 10.3390/nu14020354.
  64. Tao YW, Gu YL, Mao XQ, Zhang L, Pei YF. Effects of probiotics on type II diabetes mellitus: a meta-analysis. J Transl Med. 2020;18(1):30. doi: 10.1186/s12967–020–02213–2.
  65. Timmerman HM, Koning CJ, Mulder L, Rombouts FM, Beynen AC. Monostrain, multistrain and multispecies probiotics – A comparison of functionality and efficacy. Int J Food Microbiol. 2004;96(3):219–233. doi: 10.1016/j.ijfoodmicro.2004.05.012.
  66. Kwoji ID, Aiyegoro OA, Okpeku M, Adeleke MA. Multi-­Strain Probiotics: Synergy among Isolates Enhances Biological Activities. Biology (Basel). 2021;10(4):322. doi: 10.3390/biology10040322.
  67. Collado MC, Jalonen L, Meriluoto J, Salminen S. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. Asia Pac J Clin Nutr. 2006;15(4):570–5.
  68. Андреева И. В., Стецюк О. У. Эффективность и безопасность комбинации Lactobacillus acidophilus LA‑5 и Bifidobacterium lactis ВB‑12 в гастроэнтерологии, педиатрии и аллергологии. Клиническая микробиология и антимикробная химиотерапия. 2016;18(2):113–124.
  69. Martins FS, Silva AA, Vieira AT, Barbosa FH, Arantes RM, Teixeira MM, et al. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol. 2009;191(8):623–630. doi: 10.1007/s00203–009–0491-x.
  70. Tabasco R, García-­Cayuela T, Peláez C, Requena T. Lactobacillus acidophilus La‑5 increases lactacin B production when it senses live target bacteria. Int J Food Microbiol. 2009;132(2–3):109–116. doi: 10.1016/j.ijfoodmicro.2009.04.004.
  71. Kekkonen R. Immunomodulatory Effects of Probiotic Bacteria In Healthy Adults. Academic Dissertation. Helsinki. 2008. 122 p.
  72. Collet JP, Burtin P, Gillet J, еt аl. Risk of infectious diseases in children attending different types of day-care setting. Respiration. 1994;61(suppl 1):16–19.
  73. Nafstad P, Hagen JA, Oie L, et al. Day care centers and respiratory health. Pediatrics. 1999;103(4 Pt 1):753–758.
  74. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001;322(7298):1327.
  75. Hojsak I, Snovak N, Abdović S, et al. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-­blind, placebo-­controlled trial. Clin Nutr. 2010;29(3):312–316. doi: 10.1016/j.clnu.2009.09.008.
  76. Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res. 2006;60(2):221–224.
  77. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy – a randomised, double-­blind, placebo-­controlled study. Br J Nutr. 2009;101(11):1722–1726. doi: 10.1017/S0007114508116282.
  78. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015;2: CD006895. doi: 10.1002/14651858.CD006895.pub3.
  79. Amaral MA, Guedes GHBF, Epifanio M, et al. Network meta-analysis of probiotics to prevent respiratory infections in children and adolescents. Pediatr Pulmonol. 2017;52(6):833–843. doi: 10.1002/ppul.23643.
  80. Lenoir-­Wijnkoop I, Gerlier L, Roy D, et al. The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada. PLoS One. 2016;11(11): e0166232. doi: 10.1371/journal.pone.0166232.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.